GlassScriptPhysician profile
Clayton Robert Welsh
NPI 1164002374
$5,866.88
in general payments reported to CMS, 2019-2025
10 companies · $3,806 in 2025
The $3,806 reported for 2025 was more than what 79% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $132 · 2023: $703 · 2024: $1,226 · 2025: $3,806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,230 · Travel and Lodging: $1,232 · Education: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,229.58 |
| Travel and Lodging | $1,231.54 |
| Education | $273.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,583.95 | 2022-2025 | Gamma, Pro, Pangea |
| Arthrex, INC. | $969.49 | 2025 | |
| Depuy Synthes Sales INC. | $471.22 | 2025 | Na, Lcp |
| Lightbody Medical Technologies INC | $393.13 | 2024-2025 | |
| Biocomposites INC | $181.44 | 2024 | |
| Medical Device Business Services, INC. | $121.27 | 2023-2025 | Velys, Attune, Actis |
| Medacta USA, INC. | $65.00 | 2025 | Gmk Sphere |
| Medwest Associates | $33.04 | 2023 | |
| Ethicon US, LLC | $29.49 | 2025 | Stratafix, Dermabond Prineo |
| Orthofix Medical, INC. | $18.85 | 2024 | Physio-Stim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clayton Welsh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.